Targeting dormant micrometastases: rationale, evidence to date and clinical implications
about
Breast Cancer Metastasis to the Axillary Lymph Nodes: Are Changes to the Lymph Node "Soil" Localized or Systemic?Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3-Targeted Liposomes.A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties.
P2860
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@ast
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@en
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@nl
type
label
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@ast
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@en
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@nl
prefLabel
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@ast
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@en
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@nl
P2093
P2860
P356
P1476
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
@en
P2093
Anja Bastian
Lora Bailey-Downs
Michael A Ihnat
P2860
P304
P356
10.1177/1758834015624277
P407
P577
2016-03-01T00:00:00Z